Prelude Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nice
NICE
|
+$14.2M |
| 2 |
Domo
DOMO
|
+$12.7M |
| 3 |
Netflix
NFLX
|
+$12.4M |
| 4 |
Electronic Arts
EA
|
+$12.3M |
| 5 |
DAY
Dayforce
DAY
|
+$11.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VRNA
Verona Pharma
VRNA
|
+$17.1M |
| 2 |
COOP
Mr. Cooper
COOP
|
+$13.5M |
| 3 |
K
Kellanova
K
|
+$11.9M |
| 4 |
Lumentum
LITE
|
+$9.69M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$9.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.27% |
| 2 | Healthcare | 13.54% |
| 3 | Communication Services | 10.55% |
| 4 | Consumer Discretionary | 9.61% |
| 5 | Industrials | 9.6% |
Similar funds
Prelude Capital Management's Q4 2025 Portfolio in Review
As of Q4 2025, Prelude Capital Management held 1,633 positions worth $1.36B, up 6.1% from $1.28B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Prelude Capital Management deployed $46.1M of net new capital in Q4 2025, opening 514 new positions and adding to 325 existing holdings. Its largest new stake was Nice: 117,600 shares worth $13.3M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was Lumentum, an estimated $9.69M trimmed.
- Prelude Capital Management's largest Q4 2025 buy was Nice: 117,600 shares worth $13.3M.
- Prelude Capital Management added most to Domo in Q4 2025, an estimated $12.7M increase.
- Prelude Capital Management's biggest Q4 2025 reduction was Lumentum, cutting an estimated $9.69M.
- Prelude Capital Management fully exited Verona Pharma in Q4 2025, selling an estimated $17.1M.
- Prelude Capital Management's ten largest holdings make up 14% of its $1.36B portfolio in Q4 2025.
- Prelude Capital Management opened 514 new positions and closed 373 in Q4 2025.
- Prelude Capital Management's portfolio value rose 6.1% quarter-over-quarter to $1.36B.
Based on Prelude Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.